ÂÜÀòÂÒÂ×

Mike Shaw has an extensive background in business development and corporate development within the pharmaceutical and biotechnology industry. With a strong foundation in scientific research, Mike has held key leadership roles at Leyden Labs, Genmab, CureVac, Kiadis Pharma, Ncardia, and Leiden University Medical Center. Mike also has experience in licensing, IP, and drug discovery. Their academic achievements include a PhD from the University of Bristol and a Master of Science from the University of Strathclyde. Additionally, Mike has been a Fulbright Distinguished Scholar at The Scripps Research Institute.